Track the 이엠텍 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 이엠텍 has recorded 11 insider filings. Market capitalisation: €77.8bn. The latest transaction was reported on 26 August 2026 (Purchase). Among the most active insiders: 정승규. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
이엠텍 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and distribution of pharmaceutical products and medical devices.